tiprankstipranks
Trending News
More News >
Premier Inc (PINC)
NASDAQ:PINC
Advertisement

Premier (PINC) AI Stock Analysis

Compare
172 Followers

Top Page

PINC

Premier

(NASDAQ:PINC)

Rating:61Neutral
Price Target:
$28.00
▲(8.28% Upside)
Premier's overall stock score reflects a mix of strengths and challenges. The most significant factor is the strong earnings call performance and positive future guidance, which is offset by technical indicators suggesting overbought conditions and a high valuation. Financial stability is a positive, but declining revenue and profitability margins present risks.
Positive Factors
Financial Performance
PINC's FY4Q print was ahead of expectations, driven by continued strength in Supply Chain Services leading to an overall EBITDA beat and solid initial FY26 guide.
Revenue Growth
Management indicated demand strength from hospitals and health systems for its offerings, showing signs of bearing fruit with recently signing 4 large deals.
Strategic Initiatives
Premier's acquisition of IllumiCare is aimed at enhancing its clinical decision support capabilities, aligning with its mission to drive value-based care and operational efficiency.
Negative Factors
Fee Pressures
Net admin fee pressure will remain a headwind to growth even with a slight step up in gross admin fee growth through FY26.
Market Visibility
Upward pressure on shareback rates limits visibility in the intermediate term.
Revenue Durability
There is reservation on revenue durability associated with advisory/consulting contracts.

Premier (PINC) vs. SPDR S&P 500 ETF (SPY)

Premier Business Overview & Revenue Model

Company DescriptionPremier Inc. (PINC) is a leading healthcare improvement company that operates in the healthcare sector. It provides a range of services and solutions to its members, which include hospitals, health systems, and other healthcare providers. Premier's core offerings include supply chain services, clinical and operational performance improvement consulting, data analytics, and performance benchmarking. By leveraging its extensive network and data-driven insights, Premier aims to enhance the quality of care and reduce costs for its members.
How the Company Makes MoneyPremier Inc. generates revenue primarily through membership fees from healthcare providers who participate in its cooperative purchasing programs and services. The company also earns income from consulting services aimed at improving operational efficiencies and clinical outcomes. Additionally, Premier has developed a robust analytics platform that provides valuable data insights to its members, creating another significant revenue stream. Strategic partnerships with manufacturers and suppliers further enhance its offerings and provide additional income through purchasing agreements. Overall, Premier's diversified revenue model is supported by its commitment to improving healthcare delivery and outcomes, enabling it to drive sustainable earnings.

Premier Earnings Call Summary

Earnings Call Date:Aug 19, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Nov 04, 2025
Earnings Call Sentiment Positive
Premier reported strong overall results with significant achievements in revenue, profitability, and strategic acquisitions. However, challenges persist in the Performance Services segment and fee share increases in Supply Chain Services. The company has a positive outlook for fiscal year 2026 and beyond, with expectations for growth and stabilization.
Q4-2025 Updates
Positive Updates
Strong Finish to Fiscal Year 2025
Premier exceeded expectations in overall revenue and profitability, largely due to better-than-anticipated performance in the Supply Chain Services segment.
Accelerated Share Repurchase Program
Premier completed a $200 million accelerated share repurchase program, bringing the total amount of common stock repurchased to $800 million under the $1 billion authorization.
Acquisition of IllumiCare
Premier acquired IllumiCare, enhancing their ability to deliver real-time insights at the point of care, leveraging AI capabilities.
Growth in Supply Chain Services
Gross administrative fees grew over 3% in fiscal year 2025, driven by higher contract penetration with existing members and onboarding of new members.
Positive Momentum in Advisory Business
Secured four significant advisory deals with a robust pipeline heading into fiscal 2026, expecting advisory business to return to double-digit growth.
Expected Stabilization and Growth
Anticipated growth in total net revenue, adjusted EBITDA, and adjusted EPS by fiscal year 2027, with strategic engagements and acquisitions reinforcing future growth prospects.
Negative Updates
Decline in Revenue and EPS from Continuing Operations
Fourth quarter GAAP net income and EPS from continuing operations decreased from the prior year period, mainly due to lower revenue.
Challenges in Performance Services Segment
Although there was sequential improvement, the advisory business was lower compared to the prior year period as the company continues to rebuild their sales funnel.
Increase in Aggregate Blended Fee Share
The increase in aggregate blended fee share in the Supply Chain Services segment partially offset growth, with a higher fee share anticipated in fiscal 2026.
Impact of Contract Renewals
Higher fee share from contract renewals impacted revenue, with expectations of fee share increasing to the mid-60% range in fiscal year 2026.
Company Guidance
In the Premier's fiscal 2025 fourth-quarter and full-year conference call, the company reported exceeding expectations in revenue and profitability, driven by strong performance in the Supply Chain Services segment. Total full-year revenue reached $986 million, $11 million above the midpoint of the guidance range, while adjusted EPS of $1.54 was $0.11 above the high end of the guidance range. The fourth-quarter net revenue was $258 million, with adjusted EBITDA at $71 million, translating to a margin of 27.6%. For fiscal 2026, Premier projected total net revenue between $940 million and $1 billion, with adjusted EBITDA anticipated to range from $230 million to $245 million and adjusted EPS between $1.33 and $1.43. The company also highlighted a robust pipeline in its advisory business, expecting it to return to double-digit growth, while IllumiCare's acquisition was noted as enhancing clinical decision support capabilities. Additionally, completed contracts in the August 2020 restructure were expected to lead to a fee share increase in fiscal year 2026.

Premier Financial Statement Overview

Summary
Premier's financial performance shows stability with strong gross margins and a conservative balance sheet. However, challenges are evident with declining revenue and profitability margins, indicating potential difficulties in maintaining growth and operational efficiency.
Income Statement
65
Positive
Premier's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth by 7.95%, reflecting potential challenges in maintaining sales momentum. However, the company maintains a healthy gross profit margin of 70.07% in the TTM, indicating strong cost management. The net profit margin has decreased to 5.68% in the TTM, suggesting reduced profitability. The EBIT and EBITDA margins have also declined, indicating pressure on operational efficiency.
Balance Sheet
72
Positive
The balance sheet remains stable with a low debt-to-equity ratio of 0.19 in the TTM, reflecting conservative leverage. The return on equity (ROE) is modest at 3.49%, indicating limited profitability on shareholder equity. The equity ratio is strong, suggesting a solid capital structure. However, the declining ROE trend could be a concern if it continues.
Cash Flow
68
Positive
Cash flow analysis reveals a slight decline in free cash flow growth by 1.99% in the TTM, indicating potential challenges in generating cash. The operating cash flow to net income ratio is 0.45, suggesting adequate cash generation relative to net income. The free cash flow to net income ratio remains strong at 0.81, indicating efficient cash conversion from profits.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.01B1.01B1.35B1.34B1.43B1.72B
Gross Profit733.86M743.36M888.01M896.29M885.04M837.33M
EBITDA138.00M232.90M256.97M398.26M467.15M383.67M
Net Income20.27M20.27M119.54M175.03M265.87M287.52M
Balance Sheet
Total Assets3.12B3.10B3.40B3.37B3.36B3.52B
Cash, Cash Equivalents and Short-Term Investments83.72M83.72M125.15M89.79M86.14M129.14M
Total Debt291.41M291.41M113.70M440.33M487.29M521.67M
Total Liabilities1.59B1.57B1.44B1.04B1.11B1.29B
Stockholders Equity1.53B1.53B1.96B2.33B2.25B2.23B
Cash Flow
Free Cash Flow318.78M318.78M215.37M362.24M356.79M318.53M
Operating Cash Flow401.43M401.43M296.56M444.54M444.23M407.40M
Investing Cash Flow-102.09M-102.09M-68.47M-273.62M-139.44M-174.57M
Financing Cash Flow-340.73M-340.73M-192.72M-167.27M-347.79M-203.00M

Premier Technical Analysis

Technical Analysis Sentiment
Positive
Last Price25.86
Price Trends
50DMA
22.52
Positive
100DMA
21.98
Positive
200DMA
21.09
Positive
Market Momentum
MACD
1.10
Negative
RSI
73.34
Negative
STOCH
68.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PINC, the sentiment is Positive. The current price of 25.86 is above the 20-day moving average (MA) of 24.01, above the 50-day MA of 22.52, and above the 200-day MA of 21.09, indicating a bullish trend. The MACD of 1.10 indicates Negative momentum. The RSI at 73.34 is Negative, neither overbought nor oversold. The STOCH value of 68.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PINC.

Premier Risk Analysis

Premier disclosed 45 risk factors in its most recent earnings report. Premier reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Premier Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$1.50B46.665.27%3.20%
66
Neutral
$1.50B66.331.87%6.39%
61
Neutral
$2.13B116.553.56%3.25%-24.79%-78.38%
55
Neutral
$1.09B-13.38%-6.71%-71.40%
52
Neutral
$228.42M-74.09%7.31%-7.49%
51
Neutral
$7.83B-0.18-40.10%2.29%21.46%-2.03%
49
Neutral
$557.10M-64.27%-5.24%23.59%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PINC
Premier
26.25
6.85
35.31%
OMCL
Omnicell
33.23
-12.03
-26.58%
EVH
Evolent Health
9.62
-22.24
-69.81%
GDRX
GoodRx Holdings
4.50
-3.71
-45.19%
SOPH
SOPHiA GENETICS
3.33
-0.47
-12.37%
DH
Definitive Healthcare Corp
4.04
-0.50
-11.01%

Premier Corporate Events

Executive/Board ChangesFinancial Disclosures
Premier Updates Executive Compensation Amid Market Challenges
Neutral
Aug 20, 2025

Premier, Inc. announced changes to executive compensation for fiscal year 2026, approved on August 17, 2025, to promote retention and incentivize performance amid a competitive market for executive talent. The company reported a decrease in fiscal-year 2025 fourth-quarter total net revenue by 12% from the prior-year period, with a net income drop of 70%, yet exceeded expectations in revenue and profitability due to strong results in the Supply Chain Services segment.

Business Operations and StrategyFinancial Disclosures
Premier Engages Stakeholders with July 2025 Presentation
Positive
Jul 7, 2025

Premier, Inc. announced that starting July 8, 2025, it will engage with investors and stakeholders to discuss its Stewardship Outreach presentation for July 2025. The company will not update its fiscal 2025 financial performance until the public announcement scheduled for August 18, 2025. The presentation includes forward-looking statements about Premier’s business strategies, healthcare improvements, and financial guidance, highlighting the company’s ongoing efforts to enhance technology and expand market presence. These initiatives are expected to impact Premier’s operations and industry positioning positively, offering potential growth and value creation for stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025